About Our Belief In A Cure
CSN Medical Advisory Council
The purpose of the Medical Advisory Council is to review grant submissions to determine their relevance and application to the core mission of The Cure Starts Now. They act to monitor and determine the framework of the grant process and then evaluate submissions bi-annually based upon funding abilities determined by the board. Once approved, this council then makes recommendations based on budget ability to the Strategic Advisory Council for approval.
Gavin Baumgardner, DO
Gavin Baumgardner, DO completed his education at Ohio University College of Osteopathic Medicine with residency at Doctors Hospital. He is currently with Ohio Health in the capacity of an Internal Medicine Hospitalist. He is Chair of the CSN Medical Advisory Council.
Alberto Broniscer, MD
Alberto Broniscer, MD is an Associate Member of Oncology with St. Jude Children's Research Hospital in Memphis. He specializes in pediatric high-grade glioma research.
Shana Coley, MD, PhD
Shana Coley, MD, PhD, is Chief Resident for Anatomic Pathology at Columbia University Medical Center in New York City. Her thesis research at Emory University focused on transplantation immunology, following twelve years of basic research in microbiology and immunology.
Maryam Fouladi, MD, MSc, FRCPC
Maryam Fouladi, MD, MSc, FRCPC joined the Cancer and Blood Diseases Institute (CBDI) at CCHMC in 2008 as an associate professor and medical director of the Brain Tumor Program. She is currently professor and the Marjory J. Johnson Endowed Chair in Brain Tumor Translational Research. From April 2012- April 2016, she chaired the Pediatric Brain Tumor Consortium. She has chaired multiple national and institutional phase I, II and III clinical trials of new agents for CNS malignancies through Children's Oncology Group (COG), Pediatric Brain Tumor Consortium (PBTC), Collaborative Ependymoma Research Network (CERN) and local studies. In October 2016, she began her tenure as Chair of the CNS Committee of the Children’s Oncology Group. She has extensive experience in the development and execution of trials, translational research and helping guide the agenda for pediatric neuro-oncology clinical trials nationally.
Stewart Goldman, MD
Medical director, Neuro-oncology, Gus Foundation Chair of Neuro-oncology; Associate professor of Pediatrics, Northwestern University's Feinberg School of Medicine
Nicholas Joseph Gottardo, MB ChB, FRACP, PhD
Consultant Paediatric Oncologist & Senior Research Fellow, Princess Margaret Hospital for Children and Telethon Institute for Child Health Research, Perth, Western Australia, Australia
Cynthia Hawkins, MD, PhD
Dr. Hawkins is a paediatric neuropathologist at The Hospital for Sick Children (SickKids). Her practice involves both surgical and autopsy neuropathology and includes neuro-oncologic, neuromuscular and neurodevelopmental disease.
Daniel McPherson, PhD
Daniel McPherson, PhD studied organic chemistry and biochemistry at Auburn University before becoming a Staff Scientist at Oak Ridge National Laboratory for Nuclear Medicine. Then after taking a position as Health Science Administrator for the National Institutes of Health with input into the grant administration position, he then moved to Cincinnati where he now operates as Section Head of Radiochemistry for a local drug company.
Michelle Monje Deisseroth, MD, PhD
Dr. Monje is an assistant professor of Neurology and Neurological Sciences and, by courtesy, of Pediatrics, Pathology and Neurosurgery at Stanford University. She is a pediatric neuro-oncologist and developmental neurobiologist whose laboratory is focused on elucidating DIPG developmental origins and microenvironmental determinants of growth, as well as identifying therapeutic targets for DIPG and other pediatric high-grade gliomas.
Roger J. Packer, MD
Children's National Medical Center, Senior Vice President, Center for Neuroscience and Behavioral Medicine; Director, Brain Tumor Institute; Director, Daniel and Jennifer Gilbert Neurofibromatosis Institute; Principal Investigator, Center for Neuroscience Research (CNR); Children's Research Institute (CRI)
Dannis van Vuurden, MD, PhD
Dr. van Vuurden is a pediatric oncologist / hematologist working at the VU University Medical Center (VUmc) in Amsterdam. His specific focus, both in the clinic and in translational research, is on pediatric high-grade brain tumors, with an emphasis on pediatric high-grade glioma and DIPG.